| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GLI1 mRNA | affects expression | 16483693
|
| D019256 |
Cadmium Chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GLI1 mRNA | affects cotreatment|decreases expression | 12634122
|
| C023600 |
chromium oxide |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GLI1 mRNA | affects cotreatment|decreases expression | 12634122
|
| C017133 |
chromous chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GLI1 mRNA | affects cotreatment|decreases expression | 12634122
|
| C014347 |
decitabine |
[[decitabine affects the methylation of HHIP promoter] which affects the expression of HHIP protein] which affects the expression of GLI1 mRNA | affects expression|affects methylation | 18559595
|
| D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in decreased expression of GLI1 mRNA | decreases expression | 15289156
|
| D004958 |
Estradiol |
Estradiol results in decreased expression of GLI1 mRNA | decreases expression | 15289156
|
| D004958 |
Estradiol |
Estradiol results in decreased expression of GLI1 mRNA | decreases expression | 15328011
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of GLI1 mRNA | affects expression | 17555576
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of GLI1 mRNA | decreases expression | 17942748
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GLI1 mRNA | affects cotreatment|decreases expression | 17942748
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of GLI1 mRNA | affects expression | 17109907
|
| D005472 |
Fluorouracil |
Fluorouracil results in decreased expression of GLI1 mRNA | decreases expression | 18776995
|
| D005472 |
Fluorouracil |
GLI1 protein inhibits the reaction [Fluorouracil affects the localization of PTCH1 protein] | affects localization|decreases reaction | 18776995
|
| D019833 |
Genistein |
Genistein results in decreased expression of GLI1 mRNA | decreases expression | 15289156
|
| C525593 |
JK184 |
JK184 affects the activity of GLI1 protein | affects activity | 19222062
|
| C008261 |
lead acetate |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GLI1 mRNA | affects cotreatment|decreases expression | 12634122
|
| C467746 |
propyl pyrazole triol |
propyl pyrazole triol results in decreased expression of GLI1 mRNA | decreases expression | 17109907
|
| C017947 |
sodium arsenite |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GLI1 mRNA | affects cotreatment|decreases expression | 12634122
|
| D013629 |
Tamoxifen |
Tamoxifen affects the expression of GLI1 mRNA | affects expression | 17555576
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GLI1 mRNA | affects cotreatment|decreases expression | 17942748
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GLI1 mRNA | decreases expression | 17942748
|
| D014212 |
Tretinoin |
[Tretinoin co-treated with SHH protein co-treated with FGF8 protein] results in increased expression of GLI1 mRNA | affects cotreatment|increases expression | 17085092
|
| D014635 |
Valproic Acid |
Valproic Acid results in increased expression of GLI1 mRNA | increases expression | 19101580
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.52 | 14745880 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.19 | 15322242 11752688 14514962 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.19 | 8875741 |
| MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.89 | 19490988 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.52 | 18287403 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.91 | 17505938 |
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
10.10 | 11473722 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
10.10 | 14692618 |
| MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
10.10 | 17638652 |
| MESH:D000230 |
Adenocarcinoma |
|
Genistein |
10.10 | 11473722 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
| MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.67 | 15276417 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.87 | 17306315 16712894 |
| MESH:D000505 |
Alopecia |
|
Tretinoin |
3.58 | 15955085 |
| MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.20 | 17688650 |
| MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.44 | 15469931 |
| MESH:D000740 |
Anemia |
|
Fluorouracil |
8.55 | 15504547 17963324 16511603 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.55 | 11748828 |
| MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.54 | 17497229 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.42 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.11 | 15885639 |
| MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.11 | 16412693 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.25 | 16292516 |
| MESH:D001249 |
Asthma |
|
Tretinoin |
2.33 | 16456186 |
| MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.01 | 18316065 17507914 16609825 20603192 17157402 18985861 18396377 18558336 18775368 19460635 18177632 15238991 18940202 19232924 17688650 |
| MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.36 | 16935849 |
| MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.05 | 20046352 17594078 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.80 | 12125929 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.80 | 16206674 16197459 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.76 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.93 | 15746008 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.93 | 8888407 |
| MESH:D001943 |
Breast Neoplasms |
|
decitabine |
4.71 | 19208741 18320071 |
| MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
4.71 | 17129689 15324884 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.71 | 17289903 17261762 12948864 14630087 19861407 16675129 17018787 18497071 |
| MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
4.71 | 16595493 18357371 18608205 16110121 16557594 19217205 15136595 |
| MESH:D001943 |
Breast Neoplasms |
|
Genistein |
4.71 | 17200150 16873071 16541309 |
| MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.71 | 20859285 19155303 17049068 16202921 17242785 19084267 21138602 19142967 18984771 18815881 19410462 17893378 19103187 19189212 19487384 19221464 16873071 18629630 17261762 19189210 11161223 19115204 16818667 18351453 18425577 18855134 20065188 15565566 19200415 20135344 19059307 20544844 18821012 19011961 19288272 15668708 20390343 16273361 21152245 19244106 19066611 19289846 20005174 17440819 18997820 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.71 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
4.71 | 16873071 16443354 16166294 |
| MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.55 | 16813970 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.43 | 16111702 |
| MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.64 | 16051944 |
| MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.06 | 17121937 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.06 | 16835633 |
| MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.47 | 19066611 |
| MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.13 | 16168501 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
14.00 | 16924424 15948411 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
14.00 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
14.00 | 18930000 16332177 17088986 17045692 17971768 16799960 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
14.00 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
14.00 | 16507464 17306315 15276417 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
14.00 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
14.00 | 1917145 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.00 | 18695887 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
10.72 | 19215824 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
10.72 | 17066447 16757204 18986760 16280240 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
10.72 | 18572023 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
10.72 | 16096774 16051514 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.57 | 17572228 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.34 | 16120746 18670907 18850075 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.27 | 16332659 |
| MESH:D002386 |
Cataract |
|
Tretinoin |
3.07 | 17460283 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.64 | 18566989 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.64 | 20056578 19524636 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.55 | 16129372 |
| MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.69 | 20734317 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.12 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.84 | 11677210 16919318 15861022 16105132 17333356 17681005 17110522 |
| MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.13 | 16461808 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.70 | 16354765 15340226 12621046 8697196 15668235 |
| MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.70 | 9407595 |
| MESH:D003092 |
Colitis |
|
Tretinoin |
3.66 | 17035595 |
| MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
5.84 | 17616700 |
| MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.84 | 17725105 17018589 16510598 17016597 15001691 18772588 17169374 16340194 17287894 17172411 |
| MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
5.84 | 17182828 |
| MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.62 | 18981723 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.62 | 18448328 16391804 18949393 15148649 18288408 18509181 14970324 16524972 17094418 18802399 17255274 16282729 17594712 20501625 15289873 18383874 17016601 17695437 17454858 17401013 16331619 16303861 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.02 | 14669216 17141729 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
5.42 | 19769572 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.42 | 10048152 15322242 20055451 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
5.42 | 9224671 10589399 8800419 17551590 14991402 16925845 9142499 9125849 9211117 9664655 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
5.42 | 8888407 17688650 16575769 |
| MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
4.52 | 16002989 12952375 |
| MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.76 | 16733453 |
| MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.32 | 19031437 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.29 | 16647724 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.29 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.71 | 19279558 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.71 | 19279558 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.73 | 20420201 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
3.73 | 1733752 19641884 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.73 | 11462148 |
| MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.01 | 1851702 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.34 | 12711302 11000095 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.85 | 15322242 18230668 16714409 |
| MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.85 | 18230668 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.81 | 12538720 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.81 | 19031437 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.09 | 19294695 |
| MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
11.77 | 16402032 |
| MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
11.77 | 16402032 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
23.04 | 15700306 16804899 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
23.04 | 18566989 11473722 19148513 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
23.04 | 11473722 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
23.04 | 20544844 17893378 16202921 19155303 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
23.04 | 16569247 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.98 | 9294722 10568697 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.11 | 3659116 17275665 |
| MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.89 | 16628512 3922381 |
| MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.91 | 18234410 20417680 |
| MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.55 | 6254150 7562514 6426943 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.26 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.03 | 3659116 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.44 | 16337965 16481741 15173087 17638652 16785472 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.72 | 11564622 |
| MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.72 | 16938888 9664655 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.88 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
12.88 | 19224547 14986274 |
| MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
12.88 | 14986274 19224547 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
8.12 | 16534752 16513791 15751030 16611131 16002989 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
8.12 | 16709447 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.42 | 11858732 |
| MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.86 | 16575769 |
| MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
11.06 | 19769572 |
| MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
11.06 | 8888407 18558336 |
| MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.49 | 14745880 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.15 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.49 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.49 | 17994277 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
12.70 | 16452187 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
12.70 | 16452187 |
| MESH:D005909 |
Glioblastoma |
|
Genistein |
7.11 | 16598420 |
| MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.11 | 17312396 |
| MESH:D005910 |
Glioma |
|
Fluorouracil |
2.85 | 16145905 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.57 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
12.80 | 19215824 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
12.80 | 15162350 18337622 15102660 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
12.80 | 16096774 |
| MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.13 | 16084493 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.46 | 11294989 10048152 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.46 | 9664655 14991402 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.29 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.85 | 15340226 16120746 12621046 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.00 | 15709030 |
| MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.11 | 12676792 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.72 | 17088409 |
| MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.83 | 17688650 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.02 | 8697196 16354765 15340226 18606429 16959395 |
| MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.18 | 16870215 |
| MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.53 | 16778211 |
| MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
4.40 | 12960047 14722030 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.89 | 18850075 18670907 |
| MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
11.11 | 16002989 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
11.11 | 16945680 16569931 |
| MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
4.31 | 15036965 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.42 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
decitabine |
11.06 | 17581917 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
11.06 | 17937319 |
| MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
11.06 | 15346721 12646999 |
| MESH:D007249 |
Inflammation |
|
Tamoxifen |
4.81 | 19457130 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.81 | 12878042 12200463 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.94 | 16627594 16393666 |
| MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.73 | 17994277 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.80 | 16580747 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.80 | 15992940 17551590 |
| MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
10.06 | 16962696 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
10.06 | 15618244 |
| MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
10.06 | 20008137 |
| MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
17.49 | 15003126 14681315 16762066 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
17.49 | 15610895 |
| MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
17.49 | 16985049 |
| MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
17.49 | 18625569 |
| MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
4.02 | 17184923 |
| MESH:D007938 |
Leukemia |
|
decitabine |
10.41 | 19235587 18980019 |
| MESH:D007938 |
Leukemia |
|
Genistein |
10.41 | 18980019 17468513 |
| MESH:D007938 |
Leukemia |
|
Tretinoin |
10.41 | 17143497 |
| MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
9.43 | 17236224 19117987 18454857 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.43 | 16932348 16482212 19285840 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
6.11 | 17679729 18704418 18460780 19387464 19010910 18206229 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
6.11 | 17596541 19850784 16294345 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
6.11 | 16294345 17596541 |
| MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.43 | 18055864 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.12 | 19075265 19029980 19642359 16140955 17339181 17301526 17649720 16935935 17294898 16766008 17107899 12679006 16823087 16331271 9834237 17506722 16788101 17217047 17712046 15748426 19035177 17368321 19225113 17361223 16891316 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.27 | 9224671 |
| MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.12 | 17567588 15342952 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.68 | 14659978 14716833 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
6.68 | 17823541 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.68 | 18564211 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.68 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.68 | 18397230 16248980 |
| MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
14.08 | 16712894 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
14.08 | 16603448 17045692 15113037 18383874 |
| MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
14.08 | 15276417 16712894 |
| MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
14.08 | 16684651 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.08 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.08 | 12151625 |
| MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.14 | 19095001 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.23 | 17228818 |
| MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
4.80 | 15246190 |
| MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.80 | 15276417 17306315 19931552 16712894 17077188 |
| MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.80 | 18625569 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.80 | 19555203 11884234 |
| MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.76 | 15086387 |
| MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
5.11 | 15166399 |
| MESH:D008223 |
Lymphoma |
|
decitabine |
7.62 | 19470736 |
| MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
7.62 | 15700306 |
| MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.49 | 16002989 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.72 | 19428831 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.82 | 16891317 11807958 11408345 17203775 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
9.82 | 12929590 14578162 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.82 | 14580682 19196722 11731420 16827153 19196723 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
12.55 | 19453300 |
| MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
12.55 | 19453300 |
| MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.77 | 17453147 |
| MESH:D008545 |
Melanoma |
|
decitabine |
7.24 | 17785578 16505122 |
| MESH:D008545 |
Melanoma |
|
sodium arsenite |
7.24 | 16487513 19082730 |
| MESH:D008545 |
Melanoma |
|
Tamoxifen |
7.24 | 19393235 12393984 |
| MESH:D008545 |
Melanoma |
|
Tretinoin |
7.24 | 16752155 |
| MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.15 | 15990972 |
| MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.39 | 16940565 |
| MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.16 | 18765137 18803445 |
| MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.60 | 18986760 16757204 |
| MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.31 | 18172295 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.99 | 8888407 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
12.20 | 18608210 19157545 16882708 19010910 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
12.20 | 17596541 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
12.20 | 17596541 |
| MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.84 | 17141266 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.98 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.40 | 16810080 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.40 | 17141266 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.53 | 19393235 |
| MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.50 | 19410462 |
| MESH:D009369 |
Neoplasms |
|
decitabine |
15.53 | 17925555 19116145 19470736 |
| MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
15.53 | 15313581 |
| MESH:D009369 |
Neoplasms |
|
Fluorouracil |
15.53 | 18239605 18600527 16928823 |
| MESH:D009369 |
Neoplasms |
|
sodium arsenite |
15.53 | 11559025 |
| MESH:D009369 |
Neoplasms |
|
Tretinoin |
15.53 | 16594593 16946489 |
| MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.63 | 20056578 |
| MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.97 | 19189210 19200415 19196722 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.70 | 17289903 |
| MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
30.33 | 11399458 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
30.33 | 11399458 16427766 |
| MESH:D009421 |
Nervous System Malformations |
|
Genistein |
30.33 | 16427766 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
30.33 | 14600291 |
| MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
30.33 | 9125849 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.99 | 12854658 |
| MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
11.99 | 9142499 |
| MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
11.99 | 16359493 8888407 |
| MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.41 | 16436463 |
| MESH:D010024 |
Osteoporosis |
|
Genistein |
3.22 | 19401787 |
| MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.04 | 16169203 |
| MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
14.84 | 19331143 19259094 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
14.84 | 19401270 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
14.84 | 19005980 |
| MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
14.84 | 15276417 17306315 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
14.84 | 16936753 |
| MESH:D010146 |
Pain |
|
Tretinoin |
2.87 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
8.59 | 19294695 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
8.59 | 16929163 16500647 15113037 19003803 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.59 | 15976015 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.65 | 11578682 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.22 | 12520081 |
| MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
5.14 | 14722030 |
| MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.63 | 15687265 16977796 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.52 | 18163543 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
16.07 | 17184923 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
16.07 | 11399792 11118676 11896295 11222880 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
16.07 | 20603192 |
| MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.69 | 17616702 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.84 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
1.89 | 17136230 15846301 15046698 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.89 | 16740699 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
1.89 | 19082440 18626508 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
1.89 | 15256057 16925846 15378649 |
| MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.89 | 16039940 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.89 | 15067354 |
| MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.56 | 16636307 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.28 | 15861022 16919318 |
| MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.51 | 12752131 11422049 |
| MESH:D011625 |
Pterygium |
|
Tretinoin |
4.76 | 16723453 |
| MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.97 | 18286688 18722050 15538739 16160472 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.80 | 18990726 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
18.29 | 19155313 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
18.29 | 16283617 16116481 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
18.29 | 19155313 |
| MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.06 | 15737665 19110320 |
| MESH:D012640 |
Seizures |
|
Valproic Acid |
2.71 | 15475178 11738929 17978042 16876388 14763951 3137016 11044598 1511512 |
| MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.31 | 18572023 19524636 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.31 | 16192470 |
| MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.31 | 16467112 |
| MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
19.98 | 16002989 16709447 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
19.98 | 16709447 |
| MESH:D013088 |
Spermatocele |
|
Tamoxifen |
19.98 | 16709447 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.00 | 19457130 |
| MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
9.43 | 12854658 |
| MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
9.43 | 19490988 |
| MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.51 | 12833885 |
| MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.41 | 19037991 |
| MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.41 | 19084572 17522103 19015929 18396642 17172411 16424979 17498489 18567086 16951190 15786421 |
| MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.41 | 17261132 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.58 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.11 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.87 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.18 | 17967635 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.18 | 16026305 17045167 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.66 | 19048282 |
| MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
9.70 | 16280240 |
| MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.70 | 16051514 |
| MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.20 | 17262798 |
| MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.20 | 16040207 |
| MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.49 | 3119515 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
11.83 | 19087683 17616700 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
11.83 | 16452187 16712894 17306315 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
11.83 | 16712894 11723127 17306315 16452187 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
11.83 | 16712894 8653321 17572228 |
| MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.60 | 8888407 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
22.31 | 16175088 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
22.31 | 16803524 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
22.31 | 11813266 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
22.31 | 16129372 |
| MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
5.14 | 14652134 |
| MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
9.34 | 15809267 16690809 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
9.34 | 14692618 |
| MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
12.73 | 17785578 |
| MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
12.73 | 16752155 |
| MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
4.40 | 16002989 16513791 |
| MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.39 | 17056641 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.57 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.50 | 14671159 15869587 |
| MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.02 | 16761959 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.22 | 15886252 |
| MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.93 | 16287080 |